Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Erythropoietin regulates tumour growth of human malignancies

Yasuda, Y. · 2003 · Carcinogenesis

Abstract

In addition to the chief function of erythropoietin (Epo) in promoting erythropoiesis, some other roles have been found in the brain and uterus. We have reported that signalling pathways of Epo and Epo receptor (EpoR) are involved in the tumourigenesis of ovarian and uterine cancers. To determine whether Epo plays a similar role in other malignancies, we studied the expression of Epo in several malignant human cell lines. We found that 24 malignant human cell lines examined express Epo and EpoR regardless of their origins, types, genetic characteristics and biological properties and secrete a very small amount of Epo individually and that most of them respond to hypoxic stimuli by enhanced secretion of Epo. To determine whether the Epo-EpoR pathway operates in tumours of these cell lines, we transplanted several cell lines into nude mice and confirmed the presence of Epo-responsive sites in xenografts in which the phosphorylation of the STAT5 (signal transducer and activator of transcription) is detectable. Furthermore, in nude mice we blocked the Epo signalling in xenografts of two representative cell lines, stomach choriocarcinoma and melanoma, by i.p. injections of EpoR antagonist and found inhibition of angiogenesis and survival of tumour cells leading to destruction of tumour masses and disturbances of phosphorylation of STAT5. In contrast, Epo mimetic peptide promotes angiogenesis and tumour cell survival. These findings suggest that Epo is indispensable for the growth and viability of malignant tumour and also that the deprivation of Epo signalling may be a promising therapy for human malignancy.

Overview

Integrity signals

Registry

Crossref · 10.1093/carcin/bgg060

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 257

Metadata

Authors
Yasuda, Y.
Affiliations
Kindai University (JP)
Corresponding author
Yasuda, Y.
Venue
Carcinogenesis
Published
2003-04-24
Volume
24
Issue
6
Pages
1021-1029
ISSN
  • 0143-3334 (ISSN-L)
  • 1460-2180
OpenAlex
W2102546064
Cited by
257
References
45
Citations by year
2026: 1 · 2025: 1 · 2023: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 9 · 2016: 10 · 2015: 6 · 2014: 7 · 2013: 10 · 2012: 12
FWCI
13.30
Type
journal article
Language
en
Open access
closed
Locations
  • Carcinogenesis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
erythropoietin, erythropoietin receptor, tumor growth, STAT5 phosphorylation, hypoxia, angiogenesis, tumor cell survival, choriocarcinoma, melanoma, malignant cell lines, xenografts, anti-angiogenic therapy
MeSH terms
Cell Division, Erythropoietin, Humans, Neoplasms, Neovascularization, Pathologic, Transplantation, Heterologous, Tumor Cells, Cultured, Signal Transduction, Receptors, Erythropoietin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Erythropoietin regulates tumour growth of human malignancies. https://app.cochat.ai/papers/10.1093/carcin/bgg060
The paper
Yasuda, Y. (2003). Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis. https://doi.org/10.1093/carcin/bgg060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.